These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 856462)

  • 1. Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function.
    Benjamin RS; Riggs CE; Bachur NR
    Cancer Res; 1977 May; 37(5):1416-20. PubMed ID: 856462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adriamycin metabolism in man. Evidence from urinary metabolites.
    Takanashi S; Bachur NR
    Drug Metab Dispos; 1976; 4(1):79-87. PubMed ID: 3405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols.
    Greene RF; Collins JM; Jenkins JF; Speyer JL; Myers CE
    Cancer Res; 1983 Jul; 43(7):3417-21. PubMed ID: 6850648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of adriamycin in hepatocytes isolated from the rat and the rabbit.
    Gewirtz DA; Yanovich S
    Biochem Pharmacol; 1987 Jun; 36(11):1793-8. PubMed ID: 3579974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilary disposition of adriamycin.
    Riggs CE; Benjamin RS; Serpick AA; Bachur NR
    Clin Pharmacol Ther; 1977 Aug; 22(2):234-41. PubMed ID: 884924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in adriamycin efficacy by phenobarbital.
    Reich SD; Bachur NR
    Cancer Res; 1976 Oct; 36(10):3803-6. PubMed ID: 954004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hyperthermia on the in vitro metabolism of doxorubicin.
    Dodion P; Riggs CE; Akman SR; Bachur NR
    Cancer Treat Rep; 1986 May; 70(5):625-9. PubMed ID: 3708610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pharmacokinetics of adriamycin and adriamycin-metabolites (author's transl)].
    Ehninger G; Stocker HJ; Proksch B; Wilms K
    Klin Wochenschr; 1980 Sep; 58(18):927-34. PubMed ID: 7206588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epirubicin plasma and blood pharmacokinetics after single i.v. bolus in advanced cancer patients.
    Camaggi CM; Strocchi E; Martoni A; Angelelli B; Comparsi R; Pannuti F
    Drugs Exp Clin Res; 1985; 11(4):285-94. PubMed ID: 3869807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography.
    Andrews PA; Brenner DE; Chou FT; Kubo H; Bachur NR
    Drug Metab Dispos; 1980; 8(3):152-6. PubMed ID: 6104578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin pharmacokinetics in the rabbit.
    Maniez-Devos DM; Baurain R; Trouet A; Lesne M
    J Pharmacol; 1985; 16(2):159-69. PubMed ID: 4058012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved high-performance liquid chromatography assay of doxorubicin: detection of circulating aglycones in human plasma and comparison with thin-layer chromatography.
    Brenner DE; Galloway S; Cooper J; Noone R; Hande KR
    Cancer Chemother Pharmacol; 1985; 14(2):139-45. PubMed ID: 3971478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid metabolism in isolated perfused rat liver and kidney. Experimental studies with emphasis on aldosterone.
    Egfjord M
    Acta Physiol Scand Suppl; 1995; 627():1-42. PubMed ID: 8848946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid analytic method for adriamycin and metabolites in human plasma by a thin-film fluorescence scanner.
    Watson E; Chan KK
    Cancer Treat Rep; 1976 Nov; 60(11):1611-8. PubMed ID: 1035506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects.
    Preiss R; Matthias M; Sohr R; Brockmann B; Hüller H
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S79-88. PubMed ID: 3842695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigations on the dose-dependent pharmacokinetics of adriamycin and its metabolites.
    Preiss R; Sohr R; Kittelmann B; Müller E; Haase D
    Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):156-64. PubMed ID: 2714916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and metabolism of adriamycin octanoylhydrazone (NSC 233853) in mice and rabbits.
    Egorin MJ; Clawson RE; Ross LA; Chou FT; Andrews PA; Bachur NR
    Drug Metab Dispos; 1981; 9(3):240-5. PubMed ID: 6113933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
    Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
    Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of adriamycin (doxorubicin) and its metabolites in human plasma using reversed-phase high-performance liquid chromatography and fluorescence detection.
    Pierce RN; Jatlow PI
    J Chromatogr; 1979 Dec; 164(4):471-8. PubMed ID: 541422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.